While the regulatory interaction may be indirect, our in vivo data provide novel insights and highlight the need for future studies to elucidate the mechanistic link between miR-155, RHOA, and bone resorption in the context of T2DM. The gene discussed is RHOA; the disease is type 2 diabetes mellitus.